Canaccord Genuity Initiates Coverage on Sigilon Therapeutics With Buy Rating, $6 Price Target


MT Newswires 2023

All news about SIGILON THERAPEUTICS, INC.
11:50a Canaccord Genuity Initiates Coverage on Sigilon Therapeutics With Buy Rating, $6 Price ..

MT

2022 Sigilon Therapeutics, Inc. : Notice of Delisting or Failure to Satisfy a Continued Listing..

AQ

2022 SIGILON THERAPEUTICS, INC. Management’s Discussion and Analysis of Financial Condition..

AQ

2022 Sigilon Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..

CI

2022 Sigilon Therapeutics, Inc. : Results of Operations and Financial Condition, Regulation FD ..

AQ

2022 Sigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business Highligh..

AQ

2022 Sigilon Therapeutics, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (..

AQ

2022 Sigilon Therapeutics, Inc. : Change in Directors or Principal Officers (form 8-K)

AQ

2022 Sigilon Therapeutics, Inc. Announces Resignation of Brooke Story from Her Position as M..

CI

2022 Sigilon Therapeutics : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND BUSINESS HIGHLIGH..

PU

Analyst Recommendations on SIGILON THERAPEUTICS, INC.

Sales 2022 12,5 M

Net income 2022 -51,1 M

Net cash 2022 58,4 M

P/E ratio 2022 -0,27x
Yield 2022
Capitalization 13,4 M
13,4 M
EV / Sales 2022 -3,59x
EV / Sales 2023 0,11x
Nbr of Employees 66
Free-Float 86,7%

Chart SIGILON THERAPEUTICS, INC.



Duration :


Period :




Sigilon Therapeutics, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends SIGILON THERAPEUTICS, INC.

Short Term Mid-Term Long Term
Trends Bullish Bearish Bearish

Income Statement Evolution

Sell

Buy

Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 0,41 $
Average target price 2,88 $
Spread / Average Target 596%


Leave a Comment